The FDA has granted a three-month extension for Capricor Therapeutics’ Duchenne muscular dystrophy hopeful deramiocel in ...

The FDA has placed a clinical hold on RGX-121 after small nodules or cystic masses were detected in the spines of five ...

The current classifications of vaccine recommendations could imply that not all shots require the consent of patients or ...

Following a tumultuous stretch under ex-Commissioner Marty Makary, current FDA leadership is working to restore reliability, ...

Not much is known about Boehringer Ingelheim’s drug candidate, dubbed BI 3031185, though the asset has completed at least two ...

The Phase 3 study is evaluating two doses of Novo’s Wegovy pill in people with obesity or overweight in combination with a ...

Kaos Capital in a letter to other Capricor Therapeutics shareholders called for “an immediate meeting, board change, and ...

The accelerated greenlight for Ultragenyx’s gene therapy for glycogen storage disease has raised analyst expectations for ...

Melanoma was slower to recur in patients receiving Merck and Moderna's mRNA vaccine with Keytruda, supporting use of the ...

Despite coming away with an early victory over Eli Lilly in the oral obesity face-off, analysts don’t expect Novo Nordisk’s ...

If confirmed by the Senate, Heidi Overton—officially revealed Wednesday as President Donald Trump’s choice for FDA ...

Investors had been pessimistic about the probability of success for the personalized cancer vaccine intismeran autogene, so ...